当前位置:上海富雨生物科技有限公司>>细胞库 / 细胞培养>>干细胞>> SNU-1040人结肠癌细胞、
SNU-1040 人结肠癌细胞
Catalogue No.: C1119
Product Format: a T25 flask
Culture Properties:贴壁
Complete Growth Medium: 89%IMDM+10%FBS+1%双抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.
Components
Item | Specifications |
a T25 flask | 2X106 |
Manual | 1 copy |
rates of 16-22 % with overall survival rates of 6-8 months in seriously ill patients with HNSCC who already had a first- and/or even second-line therapy. Nivolumab and Pembrolizumab are currently approved in Germany for the first and second line therapy of relapsed/pktastatic
请输入账号
请输入密码
请输验证码
以上信息由企业自行提供,信息内容的真实性、准确性和合法性由相关企业负责,化工仪器网对此不承担任何保证责任。
温馨提示:为规避购买风险,建议您在购买产品前务必确认供应商资质及产品质量。